Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,412,176 | 1,731,191 | +319,015 | $28.99M | $33.33M | 9.99% | +$4.33M |
| Roivant Sciences Ltd.SHS(ROIV) | 2,712,741 | 2,769,819 | +57,078 | $28.67M | $31.96M | 9.59% | +$3.29M |
| Merus N V | 288,668 | 421,222 | +132,554 | $17.08M | $21.04M | 6.31% | +$3.96M |
| Immunovant, Inc.(IMVT) | 1,011,879 | 671,001 | -340,878 | $26.71M | $19.13M | 5.74% | -$7.58M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 965,392 | 1,778,318 | +812,926 | $8.98M | $16.54M | 4.96% | +$7.56M |
| Amicus Therapeutics Inc COM | 1,495,047 | 1,481,809 | -13,238 | $14.83M | $15.83M | 4.75% | +$994.9K |
| Bristol-Myers Squibb Company(BMY) | 0 | 275,303 | +275,303 | $0 | $14.24M | 4.27% | +$14.24M |
| Applied Therapeutics Inc | 2,211,320 | 1,554,586 | -656,734 | $10.33M | $13.21M | 3.96% | +$2.89M |
| Crinetics Pharmaceuticals In | 551,095 | 213,815 | -337,280 | $24.68M | $10.93M | 3.28% | -$13.76M |
| Biohaven Ltd.(BHVN) | 233,255 | 216,440 | -16,815 | $8.10M | $10.82M | 3.24% | +$2.72M |
| Praxis Precision Medicines, Inc.(PRAX) | 29,259 | 174,034 | +144,775 | $1.21M | $10.01M | 3.00% | +$8.80M |
| Autolus Therapeutics plcADS(AUTL) | 2,662,732 | 2,616,602 | -46,130 | $9.27M | $9.50M | 2.85% | +$232.0K |
| Incyte Corporation(INCY) | 0 | 129,490 | +129,490 | $0 | $8.56M | 2.57% | +$8.56M |
| Denali Therapeutics Inc.(DNLI) | 251,010 | 282,050 | +31,040 | $5.83M | $8.22M | 2.46% | +$2.39M |
| Day One Biopharmaceuticals I COM | 0 | 506,978 | +506,978 | $0 | $7.06M | 2.12% | +$7.06M |
| Acelyrin Inc | 0 | 1,317,854 | +1,317,854 | $0 | $6.50M | 1.95% | +$6.50M |
| Soleno Therapeutics Inc | 0 | 123,177 | +123,177 | $0 | $6.22M | 1.87% | +$6.22M |
| Cabaletta Bio, Inc.(CABA) | 1,178,105 | 1,278,444 | +100,339 | $8.81M | $6.03M | 1.81% | -$2.78M |
| Immatics N.V.SHS(IMTX) | 502,207 | 449,735 | -52,472 | $5.84M | $5.13M | 1.54% | -$704.2K |
| Keros Therapeutics, Inc.(KROS) | 0 | 86,930 | +86,930 | $0 | $5.05M | 1.51% | +$5.05M |
| Arcellx Inc COMMON STOCK | 280,709 | 60,076 | -220,633 | $15.49M | $5.02M | 1.50% | -$10.48M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,848,582 | 1,846,792 | -1,790 | $5.85M | $4.90M | 1.47% | -$947.6K |
| Nurix Therapeutics, Inc.(NRIX) | 203,273 | 203,015 | -258 | $4.24M | $4.56M | 1.37% | +$319.4K |
| TScan Therapeutics, Inc.(TCRX) | 845,069 | 860,951 | +15,882 | $4.94M | $4.29M | 1.29% | -$656.1K |
| Zura Bio LimitedCL A(ZURA) | 0 | 1,044,168 | +1,044,168 | $0 | $4.24M | 1.27% | +$4.24M |
| IDEAYA Biosciences, Inc.(IDYA) | 101,787 | 132,703 | +30,916 | $3.57M | $4.20M | 1.26% | +$630.3K |
| Terns Pharmaceuticals Inc | 0 | 449,321 | +449,321 | $0 | $3.75M | 1.12% | +$3.75M |
| Perspective Therapeutics, Inc.(CATX) | 343,810 | 238,084 | -105,726 | $3.43M | $3.18M | 0.95% | -$249.4K |
| Pyxis Oncology, Inc.(PYXS) | 1,202,675 | 850,210 | -352,465 | $3.98M | $3.12M | 0.94% | -$860.6K |
| Neurogene Inc.(NGNE) | 78,601 | 73,299 | -5,302 | $2.86M | $3.08M | 0.92% | +$215.3K |
| UroGen Pharma Ltd.(URGN) | 0 | 241,984 | +241,984 | $0 | $3.07M | 0.92% | +$3.07M |
| Vigil Neuroscience Inc | 744,412 | 743,719 | -693 | $2.98M | $2.53M | 0.76% | -$449.0K |
| Wave Life Sciences, Inc.SHS(WVE) | 0 | 300,000 | +300,000 | $0 | $2.46M | 0.74% | +$2.46M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 94,885 | +94,885 | $0 | $2.42M | 0.72% | +$2.42M |
| Janux Therapeutics, Inc.(JANX) | 92,949 | 49,415 | -43,534 | $3.89M | $2.24M | 0.67% | -$1.65M |
| Surrozen, Inc.(SRZN) | 143,510 | 182,918 | +39,408 | $1.57M | $2.19M | 0.66% | +$619.9K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 0 | 41,268 | +41,268 | $0 | $2.16M | 0.65% | +$2.16M |
| Helix Acquisition Corp IiCL A | 200,000 | 200,000 | 0 | $2.04M | $2.09M | 0.63% | +$46.0K |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 15,014 | +15,014 | $0 | $1.88M | 0.56% | +$1.88M |
| Protara Therapeutics, Inc.(TARA) | 984,113 | 942,857 | -41,256 | $2.05M | $1.73M | 0.52% | -$321.5K |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 150,000 | 150,000 | 0 | $1.51M | $1.50M | 0.45% | -$6.0K |
| Tourmaline Bio Inc | 0 | 55,523 | +55,523 | $0 | $1.43M | 0.43% | +$1.43M |
| Capricor Therapeutics, Inc.(CAPR) | 0 | 93,638 | +93,638 | $0 | $1.42M | 0.43% | +$1.42M |
| Alkermes plcSHS(ALKS) | 0 | 48,918 | +48,918 | $0 | $1.37M | 0.41% | +$1.37M |
| Centessa Pharmaceuticals PlcADS | 0 | 83,662 | +83,662 | $0 | $1.34M | 0.40% | +$1.34M |
| MBX Biosciences, Inc.(MBX) | 0 | 50,000 | +50,000 | $0 | $1.30M | 0.39% | +$1.30M |
| Cytokinetics, Incorporated(CYTK) | 0 | 14,464 | +14,464 | $0 | $763.7K | 0.23% | +$763.7K |
| Revolution Medicines, Inc.(RVMD) | 0 | 16,654 | +16,654 | $0 | $755.3K | 0.23% | +$755.3K |
| Astria Therapeutics Inc | 0 | 56,287 | +56,287 | $0 | $618.9K | 0.19% | +$618.9K |
| Edgewise Therapeutics, Inc.(EWTX) | 271,057 | 19,900 | -251,157 | $4.88M | $531.1K | 0.16% | -$4.35M |
| Black Diamond Therapeutics I | 674,198 | 0 | -674,198 | $3.14M | $0 | — | -$3.14M |
| Celldex Therapeutics, Inc.(CLDX) | 144,467 | 0 | -144,467 | $5.35M | $0 | — | -$5.35M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 101,479 | 0 | -101,479 | $4.59M | $0 | — | -$4.59M |
| Fulcrum Therapeutics, Inc.(FULC) | 696,464 | 0 | -696,464 | $4.32M | $0 | — | -$4.32M |
| GSK plcADR(GSK) | 245,933 | 0 | -245,933 | $9.47M | $0 | — | -$9.47M |
| Immunocore Holdings plcADS(IMCR) | 339,351 | 0 | -339,351 | $11.50M | $0 | — | -$11.50M |
| Insmed Incorporated(INSM) | 86,980 | 0 | -86,980 | $5.83M | $0 | — | -$5.83M |
| Jasper Therapeutics, Inc.(JSPR) | 143,775 | 0 | -143,775 | $3.26M | $0 | — | -$3.26M |
| Kalvista Pharmaceuticals Inc | 736,765 | 0 | -736,765 | $8.68M | $0 | — | -$8.68M |
| Larimar Therapeutics, Inc.(LRMR) | 704,349 | 0 | -704,349 | $5.11M | $0 | — | -$5.11M |
| Merck & Co., Inc.(MRK) | 81,508 | 0 | -81,508 | $10.15M | $0 | — | -$10.15M |
| Silence Therapeutics plcADS(SLN) | 124,866 | 0 | -124,866 | $2.37M | $0 | — | -$2.37M |
| Spyre Therapeutics, Inc.(SYRE) | 150,450 | 0 | -150,450 | $3.54M | $0 | — | -$3.54M |